Goserelin can generally prevent prostate cancer metastasis. Goserelin is a synthetic luteinizing hormone-releasing hormone analog, which can reduce the level of sex hormones in the body after use, and is mainly used for the treatment of hormone-sensitive prostate cancer and breast cancer, which can inhibit the development of tumors, inhibit tumor progression and metastasis, and can generally prevent metastasis of prostate cancer, and, in addition, can also be used for the treatment of endometriosis. Adverse reactions such as rash, mild swelling at the injection site, decreased libido, breast swelling and hardness, and bone pain may occur after the use of Goserelin, and women’s use may cause a decrease in the mineral density of bones, therefore, this drug should be used with caution in women suffering from metabolic bone diseases, such as patients suffering from osteoporosis. It is recommended that patients who need specific drugs, please use under the guidance of a specialist physician or pharmacist, do not blindly take medication on your own to avoid delays.